Search
for
Sort by
Research 361–390 of 1000+
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- Modulating metal-organic frameworks by surface engineering of stearic acid modification for follicular drug delivery and enhanced hair growth promotion
- Imported cutaneous Leishmaniasis in Japan
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)
- 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
- Concomitant acute alopecia and profound bone marrow suppression: An unusual manifestation of azathioprine toxicity
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Finasteride: risk of suicidality and depression
- Cemiplimab-Induced Alopecia Areata
- P‐51 Drug‐induced erythema multiforme or drug‐induced pemphigus foliaceus: a case report
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Drug‐Induced Liver Failure Following Topical Minoxidil: A Case Report
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- British Cosmetic Dermatology Group
- Analysis of Chemical Components in Cosmetics and Their Effects on Human Health and Controversies
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Retinal artery occlusion as a probable idiosyncratic reaction to topical minoxidil: a case report
- Nanoparticles in wound healing from hope to promise from promise to routine
- Xerostomia as a Rare Adverse Effect of Low‐Dose Oral Minoxidil: A Case Report With Recurrence After Rechallenge
- Dermatological drugs, topical agents, and cosmetics
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study